Open AccessEchocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
Author(s) -
Jorge Melero Polo,
Ana Roteta Unceta-Barrenechea,
Pablo Revilla Martí,
Raquel Pérez-Palacios,
Anyuli Gracia Gutiérrez,
E. Bueno Juana,
Alejandro Andrés Gracia,
Saida Atienza Ayala,
Miguel Ángel Aibar Arregui
Publication year - 2023
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0085
Subject(s) - medicine , cardiology , left ventricular hypertrophy , cardiac amyloidosis , amyloidosis , heart failure , blood pressure
Cardiac amyloidosis (CA), following a non-invasive diagnosis, constitutes an increasingly prevalent heart failure (HF) etiology. This study aims to determine which echocardiography findings help to diagnose CA in patients with left ventricular hypertrophy (LVH) admitted for decompensated HF.